SARAH CHOI: Open Payments
NPI 1831527431 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 19 payments from 6 companies in 2025. Trend: 2023 $409 · 2024 $743 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $133 |
| Amgen Inc. | 4 | $80 |
| Novo Nordisk Inc | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $39 |
| Lilly USA, LLC | 1 | $17 |
Products named: AREXVY, EVENITY, JARDIANCE, UBRELVY, Wegovy, TRELEGY ELLIPTA, Ozempic, Rybelsus.
Industry payments across CA — which companies pay providers there.
